IperionX Limited (ASX:IPX)
Australia
· Delayed Price · Currency is AUD
5.02
+0.15 (3.08%)
At close: Dec 5, 2025
IperionX Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Selling, General & Admin | 13.07 | 8 | 6.65 | 6.26 | 1.56 | |
| Research & Development | 12.57 | 8.66 | 5.6 | 1.08 | - | |
| Other Operating Expenses | 1.18 | 0.21 | - | - | - | |
| Operating Expenses | 39.27 | 22.62 | 17.66 | 21.87 | 8.82 | |
| Operating Income | -39.27 | -22.62 | -17.66 | -21.87 | -8.82 | |
| Interest Expense | -0.28 | -0.12 | -0.09 | -0.04 | -0 | |
| Interest & Investment Income | 2.2 | 0.55 | 0.14 | 0.4 | 0.01 | |
| Currency Exchange Gain (Loss) | 1.35 | -0.05 | 0.35 | - | - | |
| Other Non Operating Income (Expenses) | 0.91 | 0.61 | 0.06 | -0.01 | -0 | |
| EBT Excluding Unusual Items | -35.09 | -21.63 | -17.19 | -21.52 | -8.83 | |
| Gain (Loss) on Sale of Investments | - | - | -0.25 | - | - | |
| Gain (Loss) on Sale of Assets | -0.26 | -0.02 | - | - | - | |
| Asset Writedown | - | -0.2 | - | - | - | |
| Other Unusual Items | - | - | - | - | -5.61 | |
| Pretax Income | -35.35 | -21.84 | -17.44 | -21.52 | -14.43 | |
| Net Income | -35.35 | -21.84 | -17.44 | -21.52 | -14.43 | |
| Net Income to Common | -35.35 | -21.84 | -17.44 | -21.52 | -14.43 | |
| Shares Outstanding (Basic) | 297 | 218 | 168 | 135 | 69 | |
| Shares Outstanding (Diluted) | 297 | 218 | 168 | 135 | 69 | |
| Shares Change (YoY) | 36.29% | 29.65% | 24.83% | 95.66% | 119.52% | |
| EPS (Basic) | -0.12 | -0.10 | -0.10 | -0.16 | -0.21 | |
| EPS (Diluted) | -0.12 | -0.10 | -0.10 | -0.16 | -0.21 | |
| Free Cash Flow | -39.41 | -26.68 | -18.57 | -14.95 | -4.51 | |
| Free Cash Flow Per Share | -0.13 | -0.12 | -0.11 | -0.11 | -0.07 | |
| EBITDA | -37.79 | -22.49 | -17.48 | -21.84 | -8.82 | |
| D&A For EBITDA | 1.48 | 0.12 | 0.18 | 0.03 | 0 | |
| EBIT | -39.27 | -22.62 | -17.66 | -21.87 | -8.82 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.